Vimarsana
Biggest News Aggregation in the World

Page 22 - Synlogic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synlogic Inc Today - Breaking & Trending Today

Phenylketonuria Treatment Market to record USD 481.45 Mn growth | 34% of growth to originate from North America - Vimarsana News

Phenylketonuria Treatment Market to record USD 481.45 Mn growth | 34% of growth to originate from North America

/PRNewswire/ -- The global phenylketonuria treatment market is dominated by North America. The incidence of the condition is increasing in newborns in the...

Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 - Vimarsana News

Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, today announced...

Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 - Vimarsana News

Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, today announced...

Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria - Vimarsana News

Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced...

Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 - Vimarsana News

Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced...